CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 52 filers reported holding CASI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $288,000 | +8.3% | 355,552 | +7.0% | 0.00% | – |
Q4 2021 | $266,000 | -32.7% | 332,142 | 0.0% | 0.00% | – |
Q3 2021 | $395,000 | +30.8% | 332,142 | +70.5% | 0.00% | – |
Q2 2021 | $302,000 | -87.9% | 194,842 | -81.3% | 0.00% | – |
Q1 2021 | $2,495,000 | -21.2% | 1,039,742 | -3.2% | 0.00% | – |
Q4 2020 | $3,168,000 | +103.5% | 1,074,024 | +5.5% | 0.00% | – |
Q3 2020 | $1,557,000 | -34.8% | 1,017,612 | +6.5% | 0.00% | – |
Q2 2020 | $2,388,000 | +28.9% | 955,232 | +5.2% | 0.00% | – |
Q1 2020 | $1,852,000 | -37.0% | 907,963 | -4.6% | 0.00% | – |
Q4 2019 | $2,940,000 | +0.6% | 951,326 | +8.7% | 0.00% | – |
Q3 2019 | $2,923,000 | +4.9% | 875,142 | +0.5% | 0.00% | – |
Q2 2019 | $2,786,000 | +22.1% | 870,778 | +9.5% | 0.00% | – |
Q1 2019 | $2,282,000 | -25.9% | 795,175 | +3.8% | 0.00% | – |
Q4 2018 | $3,081,000 | -15.8% | 766,307 | -2.2% | 0.00% | – |
Q3 2018 | $3,657,000 | -25.1% | 783,168 | +32.0% | 0.00% | – |
Q2 2018 | $4,880,000 | +4829.3% | 593,163 | +2410.3% | 0.00% | – |
Q1 2018 | $99,000 | – | 23,629 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields & Co., LLC | 951,064 | $7,827,000 | 4.06% |
Wellington Shields Capital Management, LLC | 855,056 | $7,037,000 | 1.16% |
Manatuck Hill Partners, LLC | 15,090 | $124,000 | 0.05% |
Moors & Cabot, Inc. | 22,935 | $187,000 | 0.02% |
Perceptive Advisors | 43,682 | $360,000 | 0.01% |
ROYCE & ASSOCIATES LP | 120,000 | $988,000 | 0.01% |
ALPS ADVISORS INC | 125,015 | $1,029,000 | 0.01% |
MetLife Investment Management, LLC | 26,316 | $217,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 136,518 | $1,124,000 | 0.00% |
Private Advisor Group, LLC | 15,001 | $122,000 | 0.00% |